|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stinchcombe TE and Socinski MA: Current
treatments for advanced stage non-small cell lung cancer. Proc Am
Thorac Soc. 6:233–241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mahalingam D, Mita A, Mita MM, Nawrocki ST
and Giles FJ: Targeted therapy for advanced non-small cell lung
cancers: Historical perspective, current practices, and future
development. Curr Probl Cancer. 33:73–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ogawa E, Takenaka K, Katakura H, Adachi M,
Otake Y, Toda Y, Kotani H, Manabe T, Wada H and Tanaka F:
Perimembrane Aurora-A expression is a significant prognostic factor
in correlation with proliferative activity in non-small-cell lung
cancer (NSCLC). Ann Surg Oncol. 15:547–554. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Waheed A and Sly WS: Membrane associated
carbonic anhydrase IV (CA IV): A personal and historical
perspective. Subcell Biochem. 75:157–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tashian RE: The carbonic anhydrases:
Widening perspectives on their evolution, expression and function.
BioEssays: News and reviews in molecular, cellular and
developmental biology. 10:186–192. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu XL and Sly WS: Carbonic anhydrase IV
from human lung. Purification, characterization and comparison with
membrane carbonic anhydrase from human kidney. J Biol Chem.
265:8795–8801. 1990.PubMed/NCBI
|
|
10
|
Carter ND, Fryer A, Grant AG, Hume R,
Strange RG and Wistrand PJ: Membrane specific carbonic anhydrase
(CAIV) expression in human tissues. Biochim Biophys Acta.
1026:113–116. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang DB, Lu XK, Zhang X, Li ZG and Li CX:
Carbonic anhydrase 1 is a promising biomarker for early detection
of non-small cell lung cancer. Tumour Biol. 37:553–559. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ilie M, Hofman V, Zangari J, Chiche J,
Mouroux J, Mazure NM, Pouysségur J, Brest P and Hofman P: Response
of CAIX and CAXII to in vitro re-oxygenation and clinical
significance of the combined expression in NSCLC patients. Lung
cancer. 82:16–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malentacchi F, Simi L, Nannelli C,
Andreani M, Janni A, Pastorekova S and Orlando C: Alternative
splicing variants of carbonic anhydrase IX in human non-small cell
lung cancer. Lung cancer. 64:271–276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giatromanolaki A, Koukourakis MI, Sivridis
E, Pastorek J, Wykoff CC, Gatter KC and Harris AL: Expression of
hypoxia-inducible carbonic anhydrase-9 relates to angiogenic
pathways and independently to poor outcome in non-small cell lung
cancer. Cancer Res. 61:7992–7998. 2001.PubMed/NCBI
|
|
15
|
Kim SJ, Rabbani ZN, Dewhirst MW,
Vujaskovic Z, Vollmer RT, Schreiber EG, Oosterwijk E and Kelley MJ:
Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically
resected non-small cell lung cancer. Lung cancer. 49:325–335. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu SH, Takeuchi T, Fujita J, Ishida T,
Akisawa Y, Nishimori I, Kohsaki T, Onishi S, Sonobe H and Ohtsuki
Y: Effect of carbonic anhydrase-related protein VIII expression on
lung adenocarcinoma cell growth. Lung cancer. 44:273–280. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wong BC, Zhang H, Qin L, Chen H, Fang C,
Lu A and Yang Z: Carbonic anhydrase IX-directed immunoliposomes for
targeted drug delivery to human lung cancer cells in vitro. Drug
Des Devel Ther. 8:993–1001. 2014.PubMed/NCBI
|
|
18
|
Zhang J, Tsoi H, Li X, Wang H, Gao J, Wang
K, Go MY, Ng SC, Chan FK, Sung JJ and Yu J: Carbonic anhydrase IV
inhibits colon cancer development by inhibiting the Wnt signalling
pathway through targeting the WTAP-WT1-TBL1 axis. Gut.
65:1482–1493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brambilla E, Travis WD, Colby TV, Corrin B
and Shimosato Y: The new World Health Organization classification
of lung tumours. Eur Respir J. 18:1059–1068. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren S, Peng Z, Mao JH, Yu Y, Yin C, Gao X,
Cui Z, Zhang J, Yi K, Xu W, et al: RNA-seq analysis of prostate
cancer in the Chinese population identifies recurrent gene fusions,
cancer-associated long noncoding RNAs and aberrant alternative
splicings. Cell Res. 22:806–821. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Malentacchi F, Vinci S, Melina AD, Kuncova
J, Villari D, Nesi G, Selli C, Orlando C, Pazzagli M and Pinzani P:
Urinary carbonic anhydrase IX splicing messenger RNA variants in
urogenital cancers. Urol Oncol. 34:292.e9–292.e16. 2016. View Article : Google Scholar
|
|
22
|
Ambrosio MR, Di Serio C, Danza G, Rocca
BJ, Ginori A, Prudovsky I, Marchionni N, Del Vecchio MT and
Tarantini F: Carbonic anhydrase IX is a marker of hypoxia and
correlates with higher Gleason scores and ISUP grading in prostate
cancer. Diagn Pathol. 11:452016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jamali S, Klier M, Ames S, Barros LF,
McKenna R, Deitmer JW and Becker HM: Hypoxia-induced carbonic
anhydrase IX facilitates lactate flux in human breast cancer cells
by non-catalytic function. Sci Rep. 5:136052015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Kuijk SJ, Yaromina A, Houben R,
Niemans R, Lambin P and Dubois LJ: Prognostic significance of
carbonic anhydrase IX expression in cancer patients: A
meta-analysis. Front Oncol. 6:692016. View Article : Google Scholar : PubMed/NCBI
|
